Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

RIOT US

Home Stock Screener Document Search Charting Watchlists Recent Filings

Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

RIOT US

Home Stock Screener Document Search Charting Watchlists Recent Filings

Riot Platforms, Inc.(RIOT US)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Riot Platforms, Inc.(RIOT US)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Financials & Metrics

Financials Charting Short Interest Employees

Financials & Metrics

Financials Charting Short Interest Employees

SEC Filings

SEC Filings

Financials(131)

10-QQ3ended 30 Sept 20264 Nov
10-QQ2ended 30 Jun 202610 Aug
10-QQ1ended 31 Mar 202630 Apr
10-KFY 2025ended 31 Dec 20252 Mar
10-QQ3ended 30 Sept 202530 Oct 2025
10-QQ2ended 30 Jun 202531 Jul 2025
10-QQ1ended 31 Mar 20251 May 2025
10-KFY 2024ended 31 Dec 202428 Feb 2025
10-QQ3ended 30 Sept 20244 Nov 2024
10-QQ2ended 30 Jun 202431 Jul 2024
10-KFY 2023ended 31 Dec 202323 Feb 2024
10-QQ3ended 30 Sept 20238 Nov 2023
10-QQ2ended 30 Jun 20239 Aug 2023
10-QQ1ended 31 Mar 202310 May 2023
NT 10-KFY 2022ended 31 Dec 20222 Mar 2023

Events(400)

8-KThree Months EndedNine Months EndedSeptember 30,September 30, 2026 2025 2026 2025Net income (loss)$4,034$104,480$(733,613)$27,567Interest income(5,622)(3,919)(11,558)(10,650)Interest expense2,7488,0528,05316,453Income tax expense (benefit)731,6852592,442Depreciation and amortization123,92182,929319,439244,052EBITDA125,154193,227(417,420)279,864Adjustments:Stock-based compensation expense, net of amounts capitalized21,44432,85895,82392,554Acquisition-related costs———187Change in fair value of derivatives26,323(10,792)86,537(9,939)Change in fair value of contingent consideration—1—(17,641)Loss (gain) on equity method investment - marketable securities—(28,903)—28,192Loss (gain) on sale of equipment(32)(2,742)(32)(2,263)Casualty-related charges (recoveries), net—(47)3(166)Loss on contract settlement———158,137Gain on acquisition post-close dispute settlement———(26,007)Impairment of property and equipment18,45315,27946,42515,279Other (income) expense(9)(1,344)(1,218)(1,681)Amortization of license fee revenue—(340)—(388)Adjusted EBITDA$191,333$197,197$(189,882)$516,1284 Nov
8-KEntry into a Material Definitive Agreement14 Oct
8-KAmendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics7 Oct
8-KTermination of a Material Definitive Agreement25 Sep
8-KEntry into a Material Definitive Agreement14 Aug
8-KThree Months EndedSix Months EndedJune 30,June 30, 2026 2025 2026 2025Net income (loss)$(237,170)$219,454$(737,647)$(76,913)Interest income(3,623)(3,334)(5,936)(6,731)Interest expense2,6876,0935,3058,401Income tax expense (benefit)(105)320186757Depreciation and amortization97,78483,197195,518161,123EBITDA(140,427)305,730(542,574)86,637Adjustments:Stock-based compensation expense35,58230,12074,74859,696Acquisition-related costs—111—187Change in fair value of derivatives8,36242,74760,214853Change in fair value of contingent consideration—(9,390)—(17,642)Loss (gain) on equity method investment - marketable securities—(6,143)—57,095Loss (gain) on sale of equipment—350—479Casualty-related charges (recoveries), net3(119)3(119)Loss on contract settlement—158,137—158,137Gain on acquisition post-close dispute settlement—(26,007)—(26,007)Impairment of property and equipment27,972—27,972—Other (income) expense(1,221)(244)(1,209)(337)Amortization of license fee revenue—(24)—(24)Adjusted EBITDA$(69,729)$495,268$(380,846)$318,95510 Aug
8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers15 Jun
8-KThree Months EndedMarch 31, 2026 2025Net income (loss)$(500,477)$(296,367)Interest income(2,313)(3,397)Interest expense2,6182,308Income tax expense (benefit)291437Depreciation and amortization97,73477,926EBITDA(402,147)(219,093)Adjustments:Stock-based compensation expense39,16629,576Acquisition-related costs—76Change in fair value of derivatives51,852(41,894)Change in fair value of contingent consideration—(8,252)Loss (gain) on equity method investment - marketable securities—63,238Loss (gain) on sale of equipment—129Other (income) expense12(93)Amortization of license fee revenue—(24)Adjusted EBITDA$(311,117)$(176,337)30 Apr
8-KEntry into a Material Definitive Agreement27 Apr
8-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year1 Apr
8-KYears Ended December 31, 2025 2024Net income (loss)$(663,181)$109,401Interest income(13,984)(27,166)Interest expense24,1441,985Income tax expense (benefit)(150)744Depreciation and amortization346,811212,053EBITDA(306,360)297,017Adjustments:Stock-based compensation expense125,711125,204Acquisition-related costs1875,541Change in fair value of derivative assets1,447(45,277)Change in fair value of contingent consideration(18,071)(2,459)Loss (gain) on equity method investment - marketable securities28,19269,489Loss (gain) on sale of equipment(2,267)17,429Casualty-related charges (recoveries), net(174)(2,795)Loss on contract settlement158,137—Loss on legal settlement20,000—(Gain) on acquisition post-close dispute settlement(26,007)—Impairment of property and equipment29,736—Loss on convertible notes investment5,757—Other (income) expense(2,944)(863)Amortization of license fee revenue(388)(97)Adjusted EBITDA$12,956$463,1892 Mar
8-KOther Events16 Jan
8-K/ADeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers5 Jan
8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers2 Jan
8-KEntry into a Material Definitive Agreement30 Dec 2025

Insider Ownership(598)

Form 4Howell Stephen Mitchell Jr.14 Aug
Form 4Werner Ryan D.7 Aug
Form 4Werner Ryan D.4 Aug
Form 4Howell Stephen Mitchell Jr.4 Aug
Form 4Les Jason4 Aug
Form 4Werner Ryan D.9 Jul
Form 4Leverton Jaime6 Jul
Form 4Mouton Douglas6 Jul
Form 4D'Ambrosio Lance Varro6 Jul
Form 4Turner Michael John6 Jul
Form 4Yee Colin M.6 Jul
Form 4Werner Ryan D.6 Jul
Form 4Les Jason6 Jul
Form 4Howell Stephen Mitchell Jr.6 Jul
Form 4Les Jason24 Jun

Beneficial Ownership(134)

SC 13G/ARiot Platforms, Inc.6 Nov
SC 13G/ARiot Platforms, Inc.6 Aug
SC 13GRiot Platforms, Inc.11 May
SC 13GRiot Platforms, Inc.6 May
SC 13GRiot Platforms, Inc.29 Apr
SC 13G/ARiot Platforms, Inc.27 Mar
SC 13G/ARiot Platforms, Inc.5 Feb
SC 13G/ARiot Platforms, Inc.4 Feb
SC 13GRiot Platforms, Inc.20 Nov 2025
SC 13GRiot Platforms, Inc.5 Nov 2025
SC 13D/ABitfarms Ltd18 Aug 2025
SC 13G/ARiot Platforms, Inc.14 Aug 2025
SC 13D/ABitfarms Ltd8 Aug 2025
SC 13D/ABitfarms Ltd23 Jul 2025
SC 13D/ABitfarms Ltd16 Jul 2025

Other Ownership(26)

Form 144Les Jason22 Jun
Form 144Les Jason11 May
Form 144Les Jason24 Sep 2025
Form 144Jackman William Richard10 Sep 2025
Form 144Les Jason21 Jul 2025
Form 144Riot Platforms, Inc.27 May 2025
Form 144Cho Hannah14 Mar 2025
Form 144Marleau Hubert3 Mar 2025
Form 144Les Jason10 Dec 2024
Form 144Cho Hannah14 Nov 2024
Form 144D'Ambrosio Lance Varro16 Sep 2024
Form 144Marleau Hubert14 Aug 2024
Form 144Cho Hannah7 Aug 2024
Form 144Cho Hannah28 Feb 2024
Form 144Jackman William Richard8 Dec 2023

Proxies(81)

ARSAnnual report to security holders30 Apr
DEFA14ADefinitive additional materials30 Apr
DEF 14ADefinitive proxy statement30 Apr
ARSAnnual report to security holders17 Apr 2025
DEF 14ADefinitive proxy statement17 Apr 2025
DEFA14ADefinitive additional materials17 Apr 2025
PRE 14APreliminary proxy statement7 Apr 2025
DEFA14ADefinitive additional materials20 May 2024
ARSAnnual report to security holders29 Apr 2024
DEFA14ADefinitive additional materials29 Apr 2024
DEF 14ADefinitive proxy statement29 Apr 2024
PRE 14APreliminary proxy statement16 Apr 2024
DEFA14ADefinitive additional materials1 Nov 2023
DEFA14ADefinitive additional materials17 Oct 2023
DEF 14ADefinitive proxy statement17 Oct 2023

Registrations(126)

S-8Registration statement (employee benefit plan)26 Jun
424B5Prospectus filing (Rule 424(b)(5))30 Dec 2025
424B7Prospectus filing (Rule 424(b)(7))24 Apr 2025
424B7Prospectus filing (Rule 424(b)(7))20 Dec 2024
S-3ASRAutomatic shelf registration statement (S-3)9 Aug 2024
S-8Registration statement (employee benefit plan)28 Jun 2024
Form 425Business combination communication14 Jun 2024
Form 425Business combination communication14 Jun 2024
Form 425Business combination communication12 Jun 2024
Form 425Business combination communication12 Jun 2024
Form 425Business combination communication6 Jun 2024
Form 425Business combination communication6 Jun 2024
Form 425Business combination communication29 May 2024
Form 425Business combination communication29 May 2024
Form 425Business combination communication28 May 2024

Filing Review Correspondence(26)

CORRESPFiling review correspondence13 Jan 2025
CORRESPFiling review correspondence1 Nov 2024
CORRESPFiling review correspondence2 Jul 2024
CORRESPFiling review correspondence11 Dec 2020
CORRESPFiling review correspondence13 Oct 2020
CORRESPFiling review correspondence7 May 2019
CORRESPFiling review correspondence23 Apr 2019
CORRESPFiling review correspondence23 Apr 2019
CORRESPFiling review correspondence9 Apr 2019
CORRESPFiling review correspondence3 Apr 2019
CORRESPFiling review correspondence29 Jan 2019
CORRESPFiling review correspondence29 Jan 2019
CORRESPFiling review correspondence23 Nov 2018
CORRESPFiling review correspondence23 Nov 2018
CORRESPFiling review correspondence21 Aug 2018

SEC Orders And Notices(19)

EFFECTNotice of effectiveness14 Dec 2020
EFFECTNotice of effectiveness15 Oct 2020
EFFECTNotice of effectiveness8 May 2019
EFFECTNotice of effectiveness29 Apr 2019
CT ORDERConfidential treatment order21 Aug 2018
EFFECTNotice of effectiveness22 Jan 2015
EFFECTNotice of effectiveness8 Apr 2014
EFFECTNotice of effectiveness18 Nov 2013
EFFECTNotice of effectiveness23 May 2013
EFFECTNotice of effectiveness19 Jun 2012
EFFECTNotice of effectiveness27 Jul 2011
CT ORDERConfidential treatment order26 Aug 2010
EFFECTNotice of effectiveness4 Jun 2009
CT ORDERConfidential treatment order19 Sep 2008
EFFECTNotice of effectiveness31 Jan 2008

Exempt Offerings(5)

D06b12 Feb 2019
D06b27 Dec 2017
D06b22 Mar 2017
D06b22 Mar 2017
D06b15 Sep 2016

Other(9)

SEC STAFF LETTERSEC STAFF LETTER28 Feb 2020
SEC STAFF LETTERSEC STAFF LETTER4 Feb 2020
CERTNASAUTO-GENERATED PAPER DOCUMENT27 Aug 2007
SB-2SB-221 Sep 2006
SB-2/AFORM SB-2 AMENDMENT NO 126 Oct 2005
SB-2SB-222 Aug 2005
SB-2/AFORM SB-2 AMENDMENT NO. 125 Oct 2004
SB-2SB-214 Sep 2004
NTN 10QFORM 12B2527 Sep 2002

Financials(131)

10-QQ3ended 30 Sept 20264 Nov
10-QQ2ended 30 Jun 202610 Aug
10-QQ1ended 31 Mar 202630 Apr
10-KFY 2025ended 31 Dec 20252 Mar
10-QQ3ended 30 Sept 202530 Oct 2025
10-QQ2ended 30 Jun 202531 Jul 2025
10-QQ1ended 31 Mar 20251 May 2025
10-KFY 2024ended 31 Dec 202428 Feb 2025
10-QQ3ended 30 Sept 20244 Nov 2024
10-QQ2ended 30 Jun 202431 Jul 2024
10-KFY 2023ended 31 Dec 202323 Feb 2024
10-QQ3ended 30 Sept 20238 Nov 2023
10-QQ2ended 30 Jun 20239 Aug 2023
10-QQ1ended 31 Mar 202310 May 2023
NT 10-KFY 2022ended 31 Dec 20222 Mar 2023

Events(400)

8-KThree Months EndedNine Months EndedSeptember 30,September 30, 2026 2025 2026 2025Net income (loss)$4,034$104,480$(733,613)$27,567Interest income(5,622)(3,919)(11,558)(10,650)Interest expense2,7488,0528,05316,453Income tax expense (benefit)731,6852592,442Depreciation and amortization123,92182,929319,439244,052EBITDA125,154193,227(417,420)279,864Adjustments:Stock-based compensation expense, net of amounts capitalized21,44432,85895,82392,554Acquisition-related costs———187Change in fair value of derivatives26,323(10,792)86,537(9,939)Change in fair value of contingent consideration—1—(17,641)Loss (gain) on equity method investment - marketable securities—(28,903)—28,192Loss (gain) on sale of equipment(32)(2,742)(32)(2,263)Casualty-related charges (recoveries), net—(47)3(166)Loss on contract settlement———158,137Gain on acquisition post-close dispute settlement———(26,007)Impairment of property and equipment18,45315,27946,42515,279Other (income) expense(9)(1,344)(1,218)(1,681)Amortization of license fee revenue—(340)—(388)Adjusted EBITDA$191,333$197,197$(189,882)$516,1284 Nov
8-KEntry into a Material Definitive Agreement14 Oct
8-KAmendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics7 Oct
8-KTermination of a Material Definitive Agreement25 Sep
8-KEntry into a Material Definitive Agreement14 Aug
8-KThree Months EndedSix Months EndedJune 30,June 30, 2026 2025 2026 2025Net income (loss)$(237,170)$219,454$(737,647)$(76,913)Interest income(3,623)(3,334)(5,936)(6,731)Interest expense2,6876,0935,3058,401Income tax expense (benefit)(105)320186757Depreciation and amortization97,78483,197195,518161,123EBITDA(140,427)305,730(542,574)86,637Adjustments:Stock-based compensation expense35,58230,12074,74859,696Acquisition-related costs—111—187Change in fair value of derivatives8,36242,74760,214853Change in fair value of contingent consideration—(9,390)—(17,642)Loss (gain) on equity method investment - marketable securities—(6,143)—57,095Loss (gain) on sale of equipment—350—479Casualty-related charges (recoveries), net3(119)3(119)Loss on contract settlement—158,137—158,137Gain on acquisition post-close dispute settlement—(26,007)—(26,007)Impairment of property and equipment27,972—27,972—Other (income) expense(1,221)(244)(1,209)(337)Amortization of license fee revenue—(24)—(24)Adjusted EBITDA$(69,729)$495,268$(380,846)$318,95510 Aug
8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers15 Jun
8-KThree Months EndedMarch 31, 2026 2025Net income (loss)$(500,477)$(296,367)Interest income(2,313)(3,397)Interest expense2,6182,308Income tax expense (benefit)291437Depreciation and amortization97,73477,926EBITDA(402,147)(219,093)Adjustments:Stock-based compensation expense39,16629,576Acquisition-related costs—76Change in fair value of derivatives51,852(41,894)Change in fair value of contingent consideration—(8,252)Loss (gain) on equity method investment - marketable securities—63,238Loss (gain) on sale of equipment—129Other (income) expense12(93)Amortization of license fee revenue—(24)Adjusted EBITDA$(311,117)$(176,337)30 Apr
8-KEntry into a Material Definitive Agreement27 Apr
8-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year1 Apr
8-KYears Ended December 31, 2025 2024Net income (loss)$(663,181)$109,401Interest income(13,984)(27,166)Interest expense24,1441,985Income tax expense (benefit)(150)744Depreciation and amortization346,811212,053EBITDA(306,360)297,017Adjustments:Stock-based compensation expense125,711125,204Acquisition-related costs1875,541Change in fair value of derivative assets1,447(45,277)Change in fair value of contingent consideration(18,071)(2,459)Loss (gain) on equity method investment - marketable securities28,19269,489Loss (gain) on sale of equipment(2,267)17,429Casualty-related charges (recoveries), net(174)(2,795)Loss on contract settlement158,137—Loss on legal settlement20,000—(Gain) on acquisition post-close dispute settlement(26,007)—Impairment of property and equipment29,736—Loss on convertible notes investment5,757—Other (income) expense(2,944)(863)Amortization of license fee revenue(388)(97)Adjusted EBITDA$12,956$463,1892 Mar
8-KOther Events16 Jan
8-K/ADeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers5 Jan
8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers2 Jan
8-KEntry into a Material Definitive Agreement30 Dec 2025

Insider Ownership(598)

Form 4Howell Stephen Mitchell Jr.14 Aug
Form 4Werner Ryan D.7 Aug
Form 4Werner Ryan D.4 Aug
Form 4Howell Stephen Mitchell Jr.4 Aug
Form 4Les Jason4 Aug
Form 4Werner Ryan D.9 Jul
Form 4Leverton Jaime6 Jul
Form 4Mouton Douglas6 Jul
Form 4D'Ambrosio Lance Varro6 Jul
Form 4Turner Michael John6 Jul
Form 4Yee Colin M.6 Jul
Form 4Werner Ryan D.6 Jul
Form 4Les Jason6 Jul
Form 4Howell Stephen Mitchell Jr.6 Jul
Form 4Les Jason24 Jun

Beneficial Ownership(134)

SC 13G/ARiot Platforms, Inc.6 Nov
SC 13G/ARiot Platforms, Inc.6 Aug
SC 13GRiot Platforms, Inc.11 May
SC 13GRiot Platforms, Inc.6 May
SC 13GRiot Platforms, Inc.29 Apr
SC 13G/ARiot Platforms, Inc.27 Mar
SC 13G/ARiot Platforms, Inc.5 Feb
SC 13G/ARiot Platforms, Inc.4 Feb
SC 13GRiot Platforms, Inc.20 Nov 2025
SC 13GRiot Platforms, Inc.5 Nov 2025
SC 13D/ABitfarms Ltd18 Aug 2025
SC 13G/ARiot Platforms, Inc.14 Aug 2025
SC 13D/ABitfarms Ltd8 Aug 2025
SC 13D/ABitfarms Ltd23 Jul 2025
SC 13D/ABitfarms Ltd16 Jul 2025

Other Ownership(26)

Form 144Les Jason22 Jun
Form 144Les Jason11 May
Form 144Les Jason24 Sep 2025
Form 144Jackman William Richard10 Sep 2025
Form 144Les Jason21 Jul 2025
Form 144Riot Platforms, Inc.27 May 2025
Form 144Cho Hannah14 Mar 2025
Form 144Marleau Hubert3 Mar 2025
Form 144Les Jason10 Dec 2024
Form 144Cho Hannah14 Nov 2024
Form 144D'Ambrosio Lance Varro16 Sep 2024
Form 144Marleau Hubert14 Aug 2024
Form 144Cho Hannah7 Aug 2024
Form 144Cho Hannah28 Feb 2024
Form 144Jackman William Richard8 Dec 2023

Proxies(81)

ARSAnnual report to security holders30 Apr
DEFA14ADefinitive additional materials30 Apr
DEF 14ADefinitive proxy statement30 Apr
ARSAnnual report to security holders17 Apr 2025
DEF 14ADefinitive proxy statement17 Apr 2025
DEFA14ADefinitive additional materials17 Apr 2025
PRE 14APreliminary proxy statement7 Apr 2025
DEFA14ADefinitive additional materials20 May 2024
ARSAnnual report to security holders29 Apr 2024
DEFA14ADefinitive additional materials29 Apr 2024
DEF 14ADefinitive proxy statement29 Apr 2024
PRE 14APreliminary proxy statement16 Apr 2024
DEFA14ADefinitive additional materials1 Nov 2023
DEFA14ADefinitive additional materials17 Oct 2023
DEF 14ADefinitive proxy statement17 Oct 2023

Registrations(126)

S-8Registration statement (employee benefit plan)26 Jun
424B5Prospectus filing (Rule 424(b)(5))30 Dec 2025
424B7Prospectus filing (Rule 424(b)(7))24 Apr 2025
424B7Prospectus filing (Rule 424(b)(7))20 Dec 2024
S-3ASRAutomatic shelf registration statement (S-3)9 Aug 2024
S-8Registration statement (employee benefit plan)28 Jun 2024
Form 425Business combination communication14 Jun 2024
Form 425Business combination communication14 Jun 2024
Form 425Business combination communication12 Jun 2024
Form 425Business combination communication12 Jun 2024
Form 425Business combination communication6 Jun 2024
Form 425Business combination communication6 Jun 2024
Form 425Business combination communication29 May 2024
Form 425Business combination communication29 May 2024
Form 425Business combination communication28 May 2024

Filing Review Correspondence(26)

CORRESPFiling review correspondence13 Jan 2025
CORRESPFiling review correspondence1 Nov 2024
CORRESPFiling review correspondence2 Jul 2024
CORRESPFiling review correspondence11 Dec 2020
CORRESPFiling review correspondence13 Oct 2020
CORRESPFiling review correspondence7 May 2019
CORRESPFiling review correspondence23 Apr 2019
CORRESPFiling review correspondence23 Apr 2019
CORRESPFiling review correspondence9 Apr 2019
CORRESPFiling review correspondence3 Apr 2019
CORRESPFiling review correspondence29 Jan 2019
CORRESPFiling review correspondence29 Jan 2019
CORRESPFiling review correspondence23 Nov 2018
CORRESPFiling review correspondence23 Nov 2018
CORRESPFiling review correspondence21 Aug 2018

SEC Orders And Notices(19)

EFFECTNotice of effectiveness14 Dec 2020
EFFECTNotice of effectiveness15 Oct 2020
EFFECTNotice of effectiveness8 May 2019
EFFECTNotice of effectiveness29 Apr 2019
CT ORDERConfidential treatment order21 Aug 2018
EFFECTNotice of effectiveness22 Jan 2015
EFFECTNotice of effectiveness8 Apr 2014
EFFECTNotice of effectiveness18 Nov 2013
EFFECTNotice of effectiveness23 May 2013
EFFECTNotice of effectiveness19 Jun 2012
EFFECTNotice of effectiveness27 Jul 2011
CT ORDERConfidential treatment order26 Aug 2010
EFFECTNotice of effectiveness4 Jun 2009
CT ORDERConfidential treatment order19 Sep 2008
EFFECTNotice of effectiveness31 Jan 2008

Exempt Offerings(5)

D06b12 Feb 2019
D06b27 Dec 2017
D06b22 Mar 2017
D06b22 Mar 2017
D06b15 Sep 2016

Other(9)

SEC STAFF LETTERSEC STAFF LETTER28 Feb 2020
SEC STAFF LETTERSEC STAFF LETTER4 Feb 2020
CERTNASAUTO-GENERATED PAPER DOCUMENT27 Aug 2007
SB-2SB-221 Sep 2006
SB-2/AFORM SB-2 AMENDMENT NO 126 Oct 2005
SB-2SB-222 Aug 2005
SB-2/AFORM SB-2 AMENDMENT NO. 125 Oct 2004
SB-2SB-214 Sep 2004
NTN 10QFORM 12B2527 Sep 2002